Shuwen Han
Datetime: 2026-07-27 15:38:30

Dr. Han Shuwen holds a Ph.D. from Zhejiang University and serves as a master's supervisor. He is the Academic Director of the Zhejiang-France Joint Laboratory for Integrated Chinese and Western Medicine in Colorectal Cancer Prevention and Treatment. He is currently leading the establishment of a Key Laboratory of Desert Medicine, an open and innovative platform integrating medical research, education, and clinical practice with engineering and information science. The laboratory focuses on special disease prevention in extreme desert environments, pathogenesis of endemic diseases, and development of traditional Chinese medicine resources, serving countries along the Belt and Road. Dr. Han's research focuses on establishing a platform integrating "biobank construction – data analysis – mechanistic exploration – translational application," with particular emphasis on gut microbiome research, the "diet-microbiota-colorectal cancer" axis, and clinical applications of intestinal microbiota. He has established a biospecimen bank of over 100,000 samples, a multimodal single-disease database, and an E. coli gene analysis system, and has led the development of group standards for fecal sample management. He also created an intelligent analysis platform integrating more than 90 bioinformatics algorithms, established a standardized evaluation system for gut microbiota and a colorectal cancer risk assessment system, and was the first to reveal the presence of endogenous bacterial DNA in tumor cells. He has participated in more than 60 research projects and published over 90 papers as first or corresponding author (H-index: 27). He holds 5 national invention patents, 5 utility model patents, and 6 software copyrights, and has participated in the release of 4 group standards. His honors include the Zhejiang Provincial Science and Technology Progress Award (third class), the 2022 Zhejiang Provincial Health Commission "Medical Rising Star," the 2023 "South Taihu Elite Program" (Leading Talent in Health Science Innovation), and the 2024 Sino-European Outstanding Young Scientist Award.